These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 10362113

  • 1. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.
    Janin N, Andrieu N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D.
    Br J Cancer; 1999 Jun; 80(7):1042-5. PubMed ID: 10362113
    [Abstract] [Full Text] [Related]

  • 2. Incidence of cancer in 161 families affected by ataxia-telangiectasia.
    Swift M, Morrell D, Massey RB, Chase CL.
    N Engl J Med; 1991 Dec 26; 325(26):1831-6. PubMed ID: 1961222
    [Abstract] [Full Text] [Related]

  • 3. Cancer risk in heterozygotes for ataxia-telangiectasia.
    Geoffroy-Perez B, Janin N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D, Andrieu N.
    Int J Cancer; 2001 Jul 15; 93(2):288-93. PubMed ID: 11410879
    [Abstract] [Full Text] [Related]

  • 4. Breast and other cancers in families with ataxia-telangiectasia.
    Swift M, Reitnauer PJ, Morrell D, Chase CL.
    N Engl J Med; 1987 May 21; 316(21):1289-94. PubMed ID: 3574400
    [Abstract] [Full Text] [Related]

  • 5. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families.
    Cavaciuti E, Laugé A, Janin N, Ossian K, Hall J, Stoppa-Lyonnet D, Andrieu N.
    Genes Chromosomes Cancer; 2005 Jan 21; 42(1):1-9. PubMed ID: 15390180
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Jan 21; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 8. Breast cancer incidence and the effect of cigarette smoking in heterozygous carriers of mutations in the ataxia-telangiectasia gene.
    Swift M, Lukin JL.
    Cancer Epidemiol Biomarkers Prev; 2008 Nov 21; 17(11):3188-92. PubMed ID: 18990761
    [Abstract] [Full Text] [Related]

  • 9. Ataxia-telangiectasia genes and breast cancer risk in a French family study.
    Andrieu N, Cavaciuti E, Laugé A, Ossian K, Janin N, Hall J, Stoppa-Lyonnet D.
    J Dairy Res; 2005 Nov 21; 72 Spec No():73-80. PubMed ID: 16180724
    [Abstract] [Full Text] [Related]

  • 10. The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
    Chen J, Birkholtz GG, Lindblom P, Rubio C, Lindblom A.
    Cancer Res; 1998 Apr 01; 58(7):1376-9. PubMed ID: 9537233
    [Abstract] [Full Text] [Related]

  • 11. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain.
    Pippard EC, Hall AJ, Barker DJ, Bridges BA.
    Cancer Res; 1988 May 15; 48(10):2929-32. PubMed ID: 3359449
    [Abstract] [Full Text] [Related]

  • 12. Cancer risk of heterozygotes with the NBN founder mutation.
    Seemanová E, Jarolim P, Seeman P, Varon R, Digweed M, Swift M, Sperling K.
    J Natl Cancer Inst; 2007 Dec 19; 99(24):1875-80. PubMed ID: 18073374
    [Abstract] [Full Text] [Related]

  • 13. [Ataxia telangiectasia: what impact in clinical oncology?].
    Stoppa-Lyonnet D, Aurias A.
    Bull Cancer; 1992 Dec 19; 79(7):645-50. PubMed ID: 1467590
    [Abstract] [Full Text] [Related]

  • 14. Variation in breast cancer risk of heterozygotes for ataxia-telangiectasia according to environmental factors.
    Geoffroy-Perez B, Janin N, Ossian K, Laugé A, Stoppa-Lyonnet D, Andrieu N.
    Int J Cancer; 2002 Jun 01; 99(4):619-23. PubMed ID: 11992555
    [Abstract] [Full Text] [Related]

  • 15. Risk of breast cancer in families of multiple affected women and men.
    Bevier M, Sundquist K, Hemminki K.
    Breast Cancer Res Treat; 2012 Apr 01; 132(2):723-8. PubMed ID: 22179927
    [Abstract] [Full Text] [Related]

  • 16. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
    Bonadona V, Sinilnikova OM, Chopin S, Antoniou AC, Mignotte H, Mathevet P, Brémond A, Martin A, Bobin JY, Romestaing P, Raudrant D, Rudigoz RC, Léoné M, Chauvin F, Easton DF, Lenoir GM, Lasset C.
    Genes Chromosomes Cancer; 2005 Aug 01; 43(4):404-13. PubMed ID: 15887246
    [Abstract] [Full Text] [Related]

  • 17. Is family history of breast cancer a marker of susceptibility to exposures in the incidence of de novo adult acute leukemia?
    Rauscher GH, Sandler DP, Poole C, Pankow J, Shore D, Bloomfield CD, Olshan AF.
    Cancer Epidemiol Biomarkers Prev; 2003 Apr 01; 12(4):289-94. PubMed ID: 12692102
    [Abstract] [Full Text] [Related]

  • 18. Malignant neoplasms in the families of patients with ataxia-telangiectasia.
    Swift M, Sholman L, Perry M, Chase C.
    Cancer Res; 1976 Jan 01; 36(1):209-15. PubMed ID: 1248000
    [Abstract] [Full Text] [Related]

  • 19. Identification of ataxia telangiectasia heterozygotes, a cancer-prone population, using the single-cell gel electrophoresis (Comet) assay.
    Djuzenova CS, Schindler D, Stopper H, Hoehn H, Flentje M, Oppitz U.
    Lab Invest; 1999 Jun 01; 79(6):699-705. PubMed ID: 10378512
    [Abstract] [Full Text] [Related]

  • 20. Genetics and epidemiology of ataxia-telangiectasia.
    Swift M.
    Kroc Found Ser; 1985 Jun 01; 19():133-46. PubMed ID: 3864935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.